TheraRadar
← Back
Data updated: Mar 29, 2026

NAVINTA LLC

ImmunologyInfectious DiseaseNeurology
Generics

NAVINTA LLC is a generic drug manufacturer focused on Immunology, Infectious Disease, Neurology. Key products include SODIUM PHENYLACETATE AND SODIUM BENZOATE.

2008
Since
21
Drugs
-
Trials
80
Approved (2yr)

Key Drugs

SODIUM PHENYLACETATE AND SODIUM BENZOATE
sodium benzoate
3 indications · 2016

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

SODIUM PHENYLBUTYRATE 2026-02-17
NICARDIPINE HYDROCHLORIDE 2025-12-18
Manufacturing (CMC)
DIAZEPAM 2025-11-14
MARAVIROC 2025-11-04
NICARDIPINE HYDROCHLORIDE 2025-10-28
SEVELAMER CARBONATE 2025-10-27
NICARDIPINE HYDROCHLORIDE 2025-08-20
DIAZEPAM 2025-08-08
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 29%
2 drugs
Infectious Disease 29%
2 drugs
Neurology 14%
1 drugs
Cardiovascular 14%
1 drugs
Oncology 14%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Immunology
AbbVie big-pharma
Immunology, Oncology, Neurology, Infectious Disease
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Cardiovascular
GSK big-pharma
Infectious Disease, Oncology, Immunology, Neurology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Infectious Disease, Neurology